Analysis
Cannabis giant makes second round of aggressive cuts as industry continues to downsize amid headwinds
Hi, what are you looking for?
Mugglehead Investment Magazine
Canada
Analysis
With Premier Horgan's stated goal of restoring 'legendary' status to provincial product, there should be more money where his mouth is
Canada
Offering 'sensible rules and regulations' would better support LPs, says NORML Canada president
Canada
While limiting the ability to market products has spurned creative workarounds, removing regulatory handcuffs would be better for business
Analysis
Shares of Hexo slipped another 5% after reporting a third-quarter net loss of $19.5 million
Analysis
The bulk value category is trending up as legal players compete with Canada's still-thriving unregulated market
Canada
Recent rule changes from Health Canada provide room to reflect on the biggest single blow to the industry's reputation
Analysis
Aaron Salz with Stoic Advisory sees a brutal year ahead for Canadian cannabis companies but brighter horizons in 2021
Canada
The mega-producer's valuation rose almost 70% on the day but is still a far-cry from where many bought in
Canada
Not only is terpene information a cost-effective way to empower consumers, but it could play an important role in tracking Canada's sought-after genetics
